ARKG

ARK Genomic Revolution Multi-Sector ETF
C

37
  • Overview
  • Efficiency
  • Tradability
  • Fit

ARKG Fund Description

The ARK Genomic Revolution Multi-Sector ETF is an actively managed fund that targets companies involved in the genomics industry.

ARKG Factset Analytics Insight

ARKG reaches across multiple sectors and geographies for companies that the advisor believes will benefit from innovations in the genomics-related industry. The reality is almost all of its holdings are in US healthcare-related companies, with biotech naturally leading the way. This is a niche fund that charges a high fee for its actively managed strategy. Because it doesnt match well with our biotech benchmark, investors should look closely at where the fund makes its bets. It is an interesting concept and there is good performance potential, but the fund's growth has been lackluster since inception. Liquidity is thin and spreads are often wide. Interested block traders will most likely have to work with the issuer, as underlying liquidity is lacking. The fund charges a high fee, though typical for an actively managed fund, and investors should consider closure risk before jumping in.

ARKG MSCI ESG Analytics Insight

The MSCI ESG Fund Quality Score measures the ability of ETF underlying holdings to manage key medium to long-term risks and opportunities arising from environmental, social, and governance factors, as determined by MSCI ESG Research LLC. As of November 21, 2017 the ARK Genomic Revolution Multi-Sector ETF MSCI ESG Fund Quality Score is 4.16 out of 10.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. ARKG ranks in the 0th percentile within its peer group and in the 12nd percentile within the global universe of all funds in MSCI ESG Fund Metrics coverage.

  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
COMPARE
RESET
Select ETFs to compare their performance:

ARKG Top 10 Countries View All

ARKG Top 10 Sectors

ARKG Top 10 Holdings View All

ARKG Summary Data

ARK
10/31/14
Open-Ended Fund
0.75%
$47M
$1.11M
0.24%

ARKG Portfolio Data

$23.35B
-13.29
6.15
0.00%
N/A
39

ARKG Index Data

No Underlying Index
Proprietary
Proprietary
Thomson Reuters Global Biotechnology & Medical Research

Related ETFs to ARKG

BBH
Total Return
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max

ARKG Portfolio Management

0.75%
--
--
--

ARKG Tax Exposures

20% / 39.6%
--
Qualified dividends
No

ARKG Fund Structure

Open-Ended Fund
No
No
No Policy
N/A
N/A
Low
Daily
Bats Book Viewer
TOP OF BOOK
SHARES/SIZEPRICE
ASKS----
----
----
----
----
BIDS----
----
----
----
----
LAST 10 TRADES
TIMEPRICESHARES
12:55:3125.26150
12:55:0625.25450
12:54:5225.25200
12:54:5225.25400
12:54:5225.251,100
12:53:1725.30100
12:13:4125.37400
12:08:0325.34100
11:32:4925.48100
11:14:0725.50125
Bats BZX Real-time Quote - 13:27:11
Daily Spread
Premium/Discount
Volume

ARKG Factset Analytics Block Liquidity

As of 11/22/17
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of ARKG. ARKG is rated a 3 out of 5.

ARKG Tradability

43,456
$1.11M
35,956
$945.11K
0.24%
$0.06
0.09%
1.2% / -1.21%
None
100%
50,000
0.72
0.04%
1.01%
--
$24.96
3

ARKG Geographic Exposure

ARKGSegment Benchmark
86.08% 94.32%
0.06% 3.42%
0.44% 1.28%
0.92% 0.98%
0.20% --
0.90% --
0.05% --
0.27% --
1.92% --

ARKGSegment Benchmark
86.13% 94.32%
0.06% 3.42%
8.75% 2.26%
5.06% --
99.37% / 0.63% 100.00% / 0.00%

ARKG Performance Statistics

0.67
1.33
1.23
1.5
0.83%
Thomson Reuters Global Biotechnology & Medical Research

ARKG MSCI ESG Ratings

4.16 / 10
--
11.54
1.22%
5.23%
26.37

ARKG BENCHMARK COMPARISON

    ARKG
    39 Holdings
    Segment Benchmark
    206 Constituents
    Shared Holdings
    16 (Count)
     
    10.81% (Weight)
ARKGSegment Benchmark
66.42% 22.52%
18.80% 27.99%
11.94% 21.75%
2.84% 27.74%
56.65 -13.29
0.80% 0.09%
High Medium